googlemarker

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 1296226.19 Face Value (Rs.) : 1 House : Sun Pharma
BSE540.254.65 (+0.87 %)
PREV CLOSE (Rs.) 535.60
OPEN PRICE (Rs.) 536.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 540.25 (500)
VOLUME 129254
TODAY'S LOW / HIGH (Rs.)534.05 543.15
52 WK LOW / HIGH (Rs.)433.15 758.5
NSE540.404.65 (+0.87 %)
PREV CLOSE( Rs. ) 535.75
OPEN PRICE (Rs.) 536.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 540.40 (27483)
VOLUME 2878772
TODAY'S LOW / HIGH(Rs.) 533.30 543.50
52 WK LOW / HIGH (Rs.)432.7 759
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
696.93
Dividend Yield(%)
0.65
TTM EPS (Rs.)
-4.90
P/E Ratio
0.00
Book Value (Rs.)
81.60
Face Value (Rs.)
1
MCap (Rs. in Mn)
1296226.19
Price/Earning (TTM)
-172.34
Price/Sales (TTM)
17.20
Price/Book (MRQ)
6.62
PAT Margin (%)
-0.45
ROCE (%)
0.70
Incorporation Year : 01-03 1993

Management Info :

Israel Makov - Chairman Dilip S Shanghvi - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrars Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
13Oct RIL, Bharti Airtel, Sun Pharma and Shr
Reliance Industries (RIL), India’s largest company by market value will..
13Oct Sun Pharma to hike stake in Ranbaxy Ma
Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries (col..
12Oct Sun Pharma receives EIR from USFDA for
Sun Pharmaceutical Industries has received an Establishment Inspection R..
QTR Jun 17 ANNUAL 17
Net Profit-12909.9-349.5
Gross Profit -12897.3 -324.4
Operating Profit -1470.2 6096.8
Net Sales 18025.2 78067
Rs. in Millions
Sanofi India (BSE)
img  4221.60 (1.48%)
M.Cap (Rs. in Cr)9722.61
Zandu Realty (BSE)
img  1324.80 (3.33%)
M.Cap (Rs. in Cr)106.83
Coral Laboratories (BSE)
img  853.25 (2.69%)
M.Cap (Rs. in Cr)304.83
Alkem Laboratories (BSE)
img  1855.90 (0.98%)
M.Cap (Rs. in Cr)22190.07
PROMOTERS
54.38%
NON-INSTITUTION
13.57%
FI/BANKS/INSURANCE
7.17%
MUTUAL FUNDS/UTI
6.55%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • SATCO CAPITAL MARKETS LTD. All rights reserved. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     336511